Dynamic Macrophages: Understanding Mechanisms of Activation as Guide to Therapy for Atherosclerotic Vascular Disease - Wikidata - awgldk - TriplyDB

Dynamic Macrophages: Understanding Mechanisms of Activation as Guide to Therapy for Atherosclerotic Vascular Disease

Dynamic Macrophages: Understanding Mechanisms of Activation as Guide to Therapy for Atherosclerotic Vascular Disease

http://www.wikidata.org/entity/Q58801536

about

Dynamic Macrophages: Understanding Mechanisms of Activation as Guide to Therapy for Atherosclerotic Vascular Disease

http://www.wikidata.org/entity/Q58801536

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Dynamic Macrophages: Understan ...... herosclerotic Vascular Disease

@en

Dynamic Macrophages: Understan ...... herosclerotic Vascular Disease

@nl

type

label

Dynamic Macrophages: Understan ...... herosclerotic Vascular Disease

@en

Dynamic Macrophages: Understan ...... herosclerotic Vascular Disease

@nl

prefLabel

Dynamic Macrophages: Understan ...... herosclerotic Vascular Disease

@en

Dynamic Macrophages: Understan ...... herosclerotic Vascular Disease

@nl

P1433

Q58801536-73D0F4D5-D3FE-4414-9E4E-3CE51414513D

P1476

Q58801536-9F642F56-5796-42FE-B850-1D17C3582280

P2093

Q58801536-47D78EB7-CE1F-400F-B855-8A8B38E952EC

Q58801536-EF3434E9-80DB-47AE-BA07-CC5D55E00842

P2860

Q58801536-016294D1-5481-4822-8CDE-AA9FEB40D633

Q58801536-01D7E926-25CA-4317-9F04-D2A8DD8F7700

Q58801536-0436D8BC-7276-4C44-A4FF-0EEA933E6878

Q58801536-04386A58-4449-4FAE-920C-3F6E53A23EE9

Q58801536-04A3D1EB-F1DB-4F7A-BC06-49C2CB3E7212

Q58801536-085A0039-194B-4E3C-B3D1-BF9AC6E42AAD

Q58801536-092FDF58-A44A-4AC5-BFBD-846F65CEC313

Q58801536-098A3E6F-D705-4EEA-AB15-7F1CD5A53A00

Q58801536-107AEAFA-E1E9-41F1-82D9-306408372234

Q58801536-1303B590-6BA8-4A84-83E0-9F48DFF69CA9

P304

Q58801536-D557C5A3-FEC3-4463-8B63-30A98767D95C

P31

Q58801536-D2F38551-0816-4847-81E0-46C86DB14689

P356

Q58801536-7ADE0A5A-CAFA-4D51-BB5B-25E97FDFE28F

P407

Q58801536-DAF13DE6-E0D2-405C-9642-0CA449805D77

P478

Q58801536-B62BD3CD-2F19-402D-97F3-20EED2379C3B

P577

Q58801536-452D69E5-1A99-448D-9E8F-24481D45E2F7

P698

Q58801536-D9F23BCD-FA16-45AA-ACC8-C04D03179457

P921

Q58801536-EEF9F5CB-535E-4503-B6C5-0F1D27AED8E0

P932

Q58801536-096E2BDE-7154-458A-ADD3-A3E3B5704842

P356

FCVM.2018.00097

P1433

Frontiers in cardiovascular medicine

P1476

Dynamic Macrophages: Understan ...... herosclerotic Vascular Disease

@en

P2093

Julius L Decano

http://www.w3.org/2001/XMLSchema#string

Masanori Aikawa

http://www.w3.org/2001/XMLSchema#string

P2860

The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism

Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation

An inflammatory cascade leading to hyperresistinemia in humans

Changing R&D; models in research-based pharmaceutical companies

Macrophages in vascular inflammation--From atherosclerosis to vasculitis

The blockade of immune checkpoints in cancer immunotherapy

Metabolic reprogramming in macrophages and dendritic cells in innate immunity

CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study

PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation

Maresin biosynthesis and identification of maresin 2, a new anti-inflammatory and pro-resolving mediator from human macrophages

P304

97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FCVM.2018.00097

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30123798

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

6086112

http://www.w3.org/2001/XMLSchema#string